A Phase 1 Study of YZJ-5053 Tablets in Participants With Advanced Solid Tumors
Clinical trial NCT06209385 · COMPLETED
Trial details
- NCT number
- NCT06209385
- Sponsor
- Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-11
- Primary completion
- 2025-04-28
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.